English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Astrazeneca
Press release submission
| Sep 16, 2018
ASTRAZENECA: US FDA approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for certain patients with relapsed or refractory hairy cell leukemia
Marian Johns
| Jan 17, 2018
FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Trending
Patient Daily
| Dec 23, 2024
Patient Advocacy Group: ‘Policymakers must remove barriers to the development and delivery of innovative’ health care
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
Discovery of replication hubs may lead to new antiviral therapies for norovirus
+
Pharmaceuticals
Patient Daily
| Dec 17, 2024
Lung association warns against combined risks of smoking and radon
+
Pharmaceuticals
Patient Daily
| Dec 20, 2024
California student returns home after receiving life-saving heart transplant
